| Followers | 202 |
| Posts | 25627 |
| Boards Moderated | 0 |
| Alias Born | 04/03/2010 |
Sunday, July 27, 2025 1:44:19 PM
Another swing trader, going all the way back to Woodford and 2015... 10 years ago. What next?
He held NWBO stock all the way through. If he thought it was a scam, he'd have had a fiduciary duty to have SOLD. But he held... His fund ultimately did poorly because he clearly did not understand new biotech companies and got in over his head. But I certainly did not think he was a savior. I wasn't investing at the time, but I was following. He was interesting. Looked like he intended to mash this company up with some other investment and I believe that did not happen because the company wanted to remain independent, or at least that was some of the chatter on here.
Whatever the case, not really relevant. We all benefitted because his investment enabled the purchase of Sawston, and the company ultimately had a good return on that property, did a sale leaseback and that helped fund the development of Sawton as a manufacturing facility. Give it a break. You guys are like ants or cockroaches... people go away, turn out the lights and when they come back, you're all over the place.
News is pending. I get that you all want it down below .20 so you can buy cheap at the expense of other investors.
It seems likely, if they were going to be rejected, we'd LIKELY know by now. Not certain, but usually rejections come faster than careful approvals.
He held NWBO stock all the way through. If he thought it was a scam, he'd have had a fiduciary duty to have SOLD. But he held... His fund ultimately did poorly because he clearly did not understand new biotech companies and got in over his head. But I certainly did not think he was a savior. I wasn't investing at the time, but I was following. He was interesting. Looked like he intended to mash this company up with some other investment and I believe that did not happen because the company wanted to remain independent, or at least that was some of the chatter on here.
Whatever the case, not really relevant. We all benefitted because his investment enabled the purchase of Sawston, and the company ultimately had a good return on that property, did a sale leaseback and that helped fund the development of Sawton as a manufacturing facility. Give it a break. You guys are like ants or cockroaches... people go away, turn out the lights and when they come back, you're all over the place.
News is pending. I get that you all want it down below .20 so you can buy cheap at the expense of other investors.
It seems likely, if they were going to be rejected, we'd LIKELY know by now. Not certain, but usually rejections come faster than careful approvals.
I own NWBO. My posts on iHub are always posted expressly as just my humble opinion (IMHO) and none are advice, just my opinion. I am NOT a financial advisor, and it is assumed that everyone is responsible for their own due diligence.
Recent NWBO News
- CNS Drug Delivery Breakthroughs Unlock Significant Biotech Market Opportunities • InvestorsHub NewsWire • 05/11/2026 01:00:00 PM
- CNS Drug Delivery Breakthroughs Unlock Significant Biotech Market Opportunities • GlobeNewswire Inc. • 05/11/2026 12:30:00 PM
- Northwest Biotherapeutics Appoints Dr. Annalisa Jenkins As Strategic Adviser To Advance Dendritic Cell Cancer Vaccine Platform • PR Newswire (US) • 04/30/2026 04:38:00 PM
- Northwest Biotherapeutics Appoints Dr. Annalisa Jenkins As Strategic Adviser To Advance Dendritic Cell Cancer Vaccine Platform • PR Newswire (US) • 04/30/2026 04:30:00 PM
- Northwest Biotherapeutics Announces Establishment Of the Company's Own Dedicated Leukapheresis Clinic • PR Newswire (US) • 04/21/2026 01:30:00 PM
- Northwest Biotherapeutics Announces Establishment Of the Company's Own Dedicated Leukapheresis Clinic • PR Newswire (US) • 04/21/2026 01:30:00 PM
- Form EFFECT - Notice of Effectiveness • Edgar (US Regulatory) • 04/21/2026 04:15:08 AM
- Form POS AM - Post-Effective amendments for registration statement • Edgar (US Regulatory) • 04/16/2026 09:25:30 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 04/07/2026 04:30:50 PM
- Form NT 10-K - Notification of inability to timely file Form 10-K 405, 10-K, 10-KSB 405, 10-KSB, 10-KT, or 10-KT405 • Edgar (US Regulatory) • 03/31/2026 09:04:37 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 01/15/2026 10:06:20 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 01/02/2026 10:14:59 PM
- Form DEF 14A - Other definitive proxy statements • Edgar (US Regulatory) • 11/28/2025 09:43:27 PM
- Form 424B5 - Prospectus [Rule 424(b)(5)] • Edgar (US Regulatory) • 11/25/2025 10:23:07 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 11/20/2025 09:26:03 PM
- Form PRE 14A - Other preliminary proxy statements • Edgar (US Regulatory) • 11/19/2025 09:15:48 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 11/14/2025 09:44:21 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 10/31/2025 04:29:10 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 10/30/2025 08:40:05 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 10/24/2025 04:28:38 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 10/14/2025 06:22:26 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 08/14/2025 09:00:38 PM
- Form 424B5 - Prospectus [Rule 424(b)(5)] • Edgar (US Regulatory) • 07/01/2025 09:04:38 PM
